Aurora Cannabis Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
4.8
Bearish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
ACB
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ currently unprofitable (-23% margin).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $6.42 (+84.5%)
1 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
ACB
PFE
—
Trailing P/E
19.4×
-31.6×
Forward P/E
9.4×
-22.5%
Profit Margin
12.4%
36.0%
Gross Margin
75.8%
-15.5%
ROE
8.9%
6.8%
Revenue Growth
-1.2%
-94.7%
Earnings Growth
—
1.32
Beta
0.39
—
Price / Book
—
$206M
Market Cap
$149.8B
$3 – $7
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →